2018 International Bladder Cancer Network
Viewing 21-30 of 30 articles
IBCN 2018: STAG2 Biomarker for Prediction of Recurrence and Progression in Papillary Non-Muscle Invasive Bladder Cancer
IBCN 2018: Novel Immune Basal Subtypes to Predict Pathologic Response to Chemotherapy and Survival Benefit in Muscle-Invasive Bladder Cancer
IBCN 2018: Combining DNA-Repair Gene Mutations and Molecular Subtyping for More Accurate Prediction of Outcome after Neoadjuvant
IBCN 2018: PPARɣ-Mediated Repression of TFAP2A Expression Identifies an Important Transcriptional Circuit in Basal-Squamous Bladder Cancer
IBCN 2018: Dysregulation of EMT Drives the Progression to Clinically Aggressive Sarcomatoid Bladder Cancer
IBCN 2018: Genomic and Transcriptomic Heterogeneity in Bladder Cancer - Impact on Clinical Decision Making?